Several biomarkers related to inflammation, such as the NLR [27,28], GPS [12,13,14], lymphocyte-CRP ratio [29,30], systemic inflammation response index [31], and CRP-albumin ratio [32,33], have been reported to be associated with prognosis in patients with a variety of cancers, including STS. Here, CRP is linked to cancer.